{"news_desk": null, "print_page": null, "section_name": "Blogs", "subsection_name": null, "byline": {"original": "By AMIE TSANG", "person": [{"rank": 1, "role": "reported", "firstname": "Amie", "organization": "", "lastname": "TSANG"}]}, "abstract": "Walgreens to Buy Rite Aid | Valeant Shows the Risk of Follow the Leader | James Staley Named Chief of Barclays", "type_of_material": "Blog", "word_count": "2172", "lead_paragraph": null, "pub_date": "2015-10-28T06:07:37Z", "document_type": "blogpost", "slideshow_credits": null, "headline": {"main": "Morning Agenda: Anheuser-Busch InBev and SABMiller Get More Time", "kicker": "News"}, "snippet": "Walgreens to Buy Rite Aid | Valeant Shows the Risk of Follow the Leader | James Staley Named Chief of Barclays", "multimedia": [], "web_url": "http://news.blogs.nytimes.com/2015/10/28/morning-agenda-anheuser-busch-inbev-and-sabmiller-get-more-time/", "keywords": [{"rank": "1", "value": "Anheuser-Busch InBev NV", "name": "organizations"}, {"rank": "11", "value": "Theranos Inc", "name": "organizations"}, {"rank": "12", "value": "Walgreen Co.", "name": "organizations"}, {"rank": "2", "value": "Cablevision Systems Corporation", "name": "organizations"}, {"rank": "3", "value": "Credit Suisse Group AG", "name": "organizations"}, {"rank": "4", "value": "Goldman Sachs Group Inc", "name": "organizations"}, {"rank": "5", "value": "KKR & Co LP", "name": "organizations"}, {"rank": "6", "value": "Molson Coors Brewing Company", "name": "organizations"}, {"rank": "7", "value": "Rite Aid Corporation", "name": "organizations"}, {"rank": "8", "value": "Securities and Exchange Commission", "name": "organizations"}, {"rank": "9", "value": "St. Joe Company", "name": "organizations"}, {"rank": "10", "value": "Starwood Hotels &amp; Resorts Worldwide Inc", "name": "organizations"}, {"rank": "1", "value": "Art", "name": "subject"}, {"rank": "11", "value": "Soros, George", "name": "subject"}, {"rank": "12", "value": "Valeant Pharmaceuticals International Inc", "name": "subject"}, {"rank": "13", "value": "Whistle-Blowers", "name": "subject"}, {"rank": "2", "value": "Barclays PLC", "name": "subject"}, {"rank": "3", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "4", "value": "Federal Reserve System", "name": "subject"}, {"rank": "5", "value": "Hedge Funds", "name": "subject"}, {"rank": "6", "value": "Initial Public Offerings", "name": "subject"}, {"rank": "7", "value": "Interest Rates", "name": "subject"}, {"rank": "8", "value": "International Business Machines Corporation", "name": "subject"}, {"rank": "9", "value": "Libor (London Interbank Offered Rate)", "name": "subject"}, {"rank": "10", "value": "Mergers, Acquisitions and Divestitures", "name": "subject"}], "blog": [], "_id": "56309ec538f0d8595b45ccbf", "source": "The New York Times"}